<DOC>
	<DOCNO>NCT00959192</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability , immunogenicity ACC-001 , investigational vaccine , subject mild moderate Alzheimer 's disease Japan .</brief_summary>
	<brief_title>Safety , Tolerability , And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>QS 21</mesh_term>
	<criteria>Diagnosis mild moderate Alzheimer 's Disease MiniMental State Examination ( MMSE ) 1626 Significant Neurological Disease Alzheimer 's disease Major psychiatric disorder Clinically significant systemic illness</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>